In concert with our previous findings in the K/BxN serum-transfer arthritis model, DMTS-treated arthritic TRPA1 WT animals did not exhibit elevated cartilage destruction compared to nonarthritic ones, whereas TRPA1 KO mice did [6]. Here, TRPA1 is linked to arthritic joint disease.